428 related articles for article (PubMed ID: 29294207)
21. [Malignant melanoma of the skin: does screening for cancer influence the incidence and mortality?].
Schubert A
Gesundheitswesen; 2012 Mar; 74(3):154-9. PubMed ID: 21305450
[TBL] [Abstract][Full Text] [Related]
22. Target: melanoma: skin cancer screenings hold promise to reduce mortality rates, but usage of widespread screening lags.
Printz C
Cancer; 2013 Jul; 119(13):2359-60. PubMed ID: 23775430
[No Abstract] [Full Text] [Related]
23. [Skin cancer screening in Germany: review after ten years].
Hübner J; Eisemann N; Brunßen A; Katalinic A
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Dec; 61(12):1536-1543. PubMed ID: 30411137
[TBL] [Abstract][Full Text] [Related]
24. Melanoma epidemiology of Austria reveals gender-related differences.
Duschek N; Skvara H; Kittler H; Delir G; Fink A; Pinkowicz A; Waldhör T
Eur J Dermatol; 2013; 23(6):872-8. PubMed ID: 24184485
[TBL] [Abstract][Full Text] [Related]
25. Why a randomized melanoma screening trial is not a good idea.
Halvorsen JA; Løberg M; Gjersvik P; Roscher I; Veierød MB; Robsahm TE; Nilsen LTN; Kalager M; Bretthauer M
Br J Dermatol; 2018 Aug; 179(2):532-533. PubMed ID: 29893490
[No Abstract] [Full Text] [Related]
26. [Turning point in skin cancer mortality : An analysis of the trend in Germany from 1998 to 2017].
Hübner J; Hübner F; Terheyden P; Katalinic A
Hautarzt; 2019 Dec; 70(12):989-992. PubMed ID: 31720720
[TBL] [Abstract][Full Text] [Related]
27. Disparities in melanoma incidence and mortality in South-Eastern Europe: Increasing incidence and divergent mortality patterns. Is progress around the corner?
Barbaric J; Sekerija M; Agius D; Coza D; Dimitrova N; Demetriou A; Safaei Diba C; Eser S; Gavric Z; Primic-Zakelj M; Zivkovic S; Zvolsky M; Bray F; Coebergh JW; Znaor A
Eur J Cancer; 2016 Mar; 55():47-55. PubMed ID: 26773419
[TBL] [Abstract][Full Text] [Related]
28. [Screening for and early detection of skin melanoma in the Netherlands].
van Roekel EH; Verbeek AL; Bonenkamp H
Ned Tijdschr Geneeskd; 2012; 156(26):A4456. PubMed ID: 22759708
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of skin cancer screening for individuals age 14 to 34 years.
Schmitt J; Seidler A; Heinisch G; Sebastian G
J Dtsch Dermatol Ges; 2011 Aug; 9(8):608-16. PubMed ID: 21501381
[TBL] [Abstract][Full Text] [Related]
30. Participation and health care provision of statutory skin cancer screening in Germany - a secondary data analysis.
Anastasiadou Z; Schäfer I; Siebert J; Günther W; Reusch M; Augustin M
J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):424-7. PubMed ID: 26856813
[TBL] [Abstract][Full Text] [Related]
31. A nationwide population-based skin cancer screening in Germany: proceedings of the first meeting of the International Task Force on Skin Cancer Screening and Prevention (September 24 and 25, 2009).
Geller AC; Greinert R; Sinclair C; Weinstock MA; Aitken J; Boniol M; Capellaro M; Doré JF; Elwood M; Fletcher SW; Gallagher R; Gandini S; Halpern AC; Katalinic A; Lucas R; Marghoob AA; Nolte S; Schüz J; Tucker MA; Volkmer B; Breitbart E
Cancer Epidemiol; 2010 Jun; 34(3):355-8. PubMed ID: 20381443
[TBL] [Abstract][Full Text] [Related]
32. Trends in the survival of patients diagnosed with malignant melanoma of the skin in the Nordic countries 1964-2003 followed up to the end of 2006.
Tryggvadóttir L; Gislum M; Hakulinen T; Klint A; Engholm G; Storm HH; Bray F
Acta Oncol; 2010 Jun; 49(5):665-72. PubMed ID: 20491525
[TBL] [Abstract][Full Text] [Related]
33. Targeting early detection of malignant melanoma of the skin.
Cooke KR; McNoe BM
N Z Med J; 1990 Nov; 103(902):551-3. PubMed ID: 2243650
[TBL] [Abstract][Full Text] [Related]
34. Skin melanoma in Saarland: incidence, survival and mortality 1970-1996.
Stang A; Stang K; Stegmaier C; Hakulinen T; Jöckel KH
Eur J Cancer Prev; 2001 Oct; 10(5):407-15. PubMed ID: 11711755
[TBL] [Abstract][Full Text] [Related]
35. Skin cancer mortality in Germany before and after the post-communist transition.
Stang A; Lampert T; Uhlemann T; Trocchi P
Int J Dermatol; 2009 Apr; 48(4):363-70. PubMed ID: 19335420
[TBL] [Abstract][Full Text] [Related]
36. Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence.
Eisemann N; Waldmann A; Geller AC; Weinstock MA; Volkmer B; Greinert R; Breitbart EW; Katalinic A
J Invest Dermatol; 2014 Jan; 134(1):43-50. PubMed ID: 23877569
[TBL] [Abstract][Full Text] [Related]
37. Time trends in incidence and mortality of cutaneous melanoma in Germany.
Garbe C; Keim U; Eigentler TK; Amaral T; Katalinic A; Holleczek B; Martus P; Leiter U
J Eur Acad Dermatol Venereol; 2019 Jul; 33(7):1272-1280. PubMed ID: 30387899
[TBL] [Abstract][Full Text] [Related]
38. Opportunistic screening strategy for cutaneous melanoma does not change the incidence of nodular and thick lesions nor reduce mortality: a population-based descriptive study in the European region with the highest incidence.
Bordoni A; Leoni-Parvex S; Peverelli S; Mazzola P; Mazzucchelli L; Spitale A
Melanoma Res; 2013 Oct; 23(5):402-7. PubMed ID: 23839077
[TBL] [Abstract][Full Text] [Related]
39. The control of melanoma in New Zealand.
Sneyd M; Cox B
N Z Med J; 2006 Sep; 119(1242):U2169. PubMed ID: 16998570
[TBL] [Abstract][Full Text] [Related]
40. Early detection and prevention of cutaneous malignant melanoma: emphasis on Swedish activities.
Ringborg U; Lagerlöf B; Broberg M; Månsson-Brahme E; Platz A; Thörn M
Med Oncol Tumor Pharmacother; 1991; 8(3):183-7. PubMed ID: 1803179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
